Delivery Order SPE2DB22D3010-SPE2DB25FP1RD
Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,057.29 firm-fixed-price delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $16,817.68 and has an ultimate completion date of March 6, 2024. The award was made on March 5, 2024, and there is no set-aside designation indicated....
- This federal contract award, valued at $12,201.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $44,531.94 with a ceiling value of $44,531.94. The award was issued by the Defense Logistics Agency (DLA) and is for the medical product DIFICID 200 MG TABLET 20S. The contract has an ultimate completion date of February 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp (the prime contractor) by the Defense Logistics Agency (DLA) for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has a ceiling value of $13,104.16 and an ultimate completion date of September 20, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,355.83 delivery order contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,664.55 firm fixed-price contract is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product, with a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,940.65, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 5, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of DIFICID 200 MG TABLET 20S medical products. The contract has a ceiling value of $10,419.42 and a completion date of November 21, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, as a firm fixed-price delivery order. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,101.92, is for the supply of DIFICID 200 MG TABLET 20S, a medical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has a period of performance through November 6, 2024. This award is associated with a...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP1RDDelivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of DIFICID 200 MG TABLET 20S, a medical product, with a ceiling value of $9,657.75 and a completion date of February 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 7/1/25, 6:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 2/13/25 |